

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exocrine pancreas development (GO:0031017) | 5.35403907 |
| 2 | signal peptide processing (GO:0006465) | 4.38282657 |
| 3 | DNA deamination (GO:0045006) | 4.18311041 |
| 4 | Golgi transport vesicle coating (GO:0048200) | 4.06152543 |
| 5 | COPI coating of Golgi vesicle (GO:0048205) | 4.06152543 |
| 6 | intestinal cholesterol absorption (GO:0030299) | 3.94702338 |
| 7 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.92551930 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.78040231 |
| 9 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.69393329 |
| 10 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.47396302 |
| 11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.47396302 |
| 12 | protein retention in ER lumen (GO:0006621) | 3.44925411 |
| 13 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.31585813 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.26463759 |
| 15 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.22118043 |
| 16 | T cell migration (GO:0072678) | 3.16836452 |
| 17 | positive regulation of B cell differentiation (GO:0045579) | 3.03448066 |
| 18 | immunoglobulin mediated immune response (GO:0016064) | 3.02695711 |
| 19 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.02260561 |
| 20 | myeloid dendritic cell differentiation (GO:0043011) | 3.01348689 |
| 21 | positive regulation of nuclease activity (GO:0032075) | 2.98350510 |
| 22 | COPII vesicle coating (GO:0048208) | 2.97466977 |
| 23 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.96451836 |
| 24 | negative regulation of cell killing (GO:0031342) | 2.95189804 |
| 25 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.95189804 |
| 26 | detection of other organism (GO:0098543) | 2.91112856 |
| 27 | detection of bacterium (GO:0016045) | 2.90678678 |
| 28 | cellular response to unfolded protein (GO:0034620) | 2.90114050 |
| 29 | response to muramyl dipeptide (GO:0032495) | 2.89484495 |
| 30 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.89174397 |
| 31 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.88161304 |
| 32 | neutrophil mediated immunity (GO:0002446) | 2.86432515 |
| 33 | positive regulation by symbiont of host defense response (GO:0052509) | 2.86268862 |
| 34 | modulation by symbiont of host defense response (GO:0052031) | 2.86268862 |
| 35 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.86268862 |
| 36 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.86268862 |
| 37 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.86268862 |
| 38 | modulation by symbiont of host immune response (GO:0052553) | 2.86268862 |
| 39 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.86117195 |
| 40 | type I interferon signaling pathway (GO:0060337) | 2.86050688 |
| 41 | cellular response to type I interferon (GO:0071357) | 2.86050688 |
| 42 | B cell receptor signaling pathway (GO:0050853) | 2.85554199 |
| 43 | regulation of nuclease activity (GO:0032069) | 2.85274569 |
| 44 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.84724741 |
| 45 | response to type I interferon (GO:0034340) | 2.84697831 |
| 46 | complement activation, classical pathway (GO:0006958) | 2.84499872 |
| 47 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.84361467 |
| 48 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.83863359 |
| 49 | regulation of cholesterol homeostasis (GO:2000188) | 2.81867675 |
| 50 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.81674319 |
| 51 | peptidyl-asparagine modification (GO:0018196) | 2.80579833 |
| 52 | tRNA methylation (GO:0030488) | 2.79692843 |
| 53 | natural killer cell activation involved in immune response (GO:0002323) | 2.75297293 |
| 54 | proline biosynthetic process (GO:0006561) | 2.75075098 |
| 55 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.74540628 |
| 56 | pinocytosis (GO:0006907) | 2.73785550 |
| 57 | cellular response to topologically incorrect protein (GO:0035967) | 2.73093230 |
| 58 | macrophage activation involved in immune response (GO:0002281) | 2.72989619 |
| 59 | glycolipid catabolic process (GO:0019377) | 2.72050433 |
| 60 | regulation of gamma-delta T cell activation (GO:0046643) | 2.71759926 |
| 61 | nucleoside diphosphate catabolic process (GO:0009134) | 2.68174599 |
| 62 | mitochondrial DNA replication (GO:0006264) | 2.67421454 |
| 63 | digestion (GO:0007586) | 2.66765247 |
| 64 | myeloid dendritic cell activation (GO:0001773) | 2.65366384 |
| 65 | ceramide catabolic process (GO:0046514) | 2.64334101 |
| 66 | glycosphingolipid catabolic process (GO:0046479) | 2.62839952 |
| 67 | peptide catabolic process (GO:0043171) | 2.61926820 |
| 68 | response to peptidoglycan (GO:0032494) | 2.61441721 |
| 69 | ER-nucleus signaling pathway (GO:0006984) | 2.61387197 |
| 70 | NIK/NF-kappaB signaling (GO:0038061) | 2.61177919 |
| 71 | regulation of B cell differentiation (GO:0045577) | 2.60862080 |
| 72 | protein N-linked glycosylation (GO:0006487) | 2.60465901 |
| 73 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.59921167 |
| 74 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.58860587 |
| 75 | proline metabolic process (GO:0006560) | 2.57362024 |
| 76 | GDP-mannose metabolic process (GO:0019673) | 2.56208422 |
| 77 | germinal center formation (GO:0002467) | 2.55326955 |
| 78 | defense response to protozoan (GO:0042832) | 2.54674510 |
| 79 | B cell homeostasis (GO:0001782) | 2.54531875 |
| 80 | T-helper 1 type immune response (GO:0042088) | 2.54058837 |
| 81 | negative regulation of interleukin-12 production (GO:0032695) | 2.52267793 |
| 82 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.51743931 |
| 83 | amino sugar catabolic process (GO:0046348) | 2.51604146 |
| 84 | cellular extravasation (GO:0045123) | 2.51346208 |
| 85 | detection of external biotic stimulus (GO:0098581) | 2.49996638 |
| 86 | valine metabolic process (GO:0006573) | 2.47767378 |
| 87 | rRNA modification (GO:0000154) | 2.47625097 |
| 88 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.47354466 |
| 89 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.44144866 |
| 90 | RNA destabilization (GO:0050779) | 2.43897695 |
| 91 | regulation of vitamin metabolic process (GO:0030656) | 2.43839380 |
| 92 | * response to endoplasmic reticulum stress (GO:0034976) | 2.43094802 |
| 93 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.42514752 |
| 94 | protein maturation by protein folding (GO:0022417) | 2.42073696 |
| 95 | embryonic process involved in female pregnancy (GO:0060136) | 2.42061970 |
| 96 | response to protozoan (GO:0001562) | 2.41208642 |
| 97 | neutrophil activation (GO:0042119) | 2.40981543 |
| 98 | mannose metabolic process (GO:0006013) | 2.40620668 |
| 99 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.39922419 |
| 100 | mature B cell differentiation (GO:0002335) | 2.39777512 |
| 101 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.39630103 |
| 102 | regulation of necroptotic process (GO:0060544) | 2.39530939 |
| 103 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.38886714 |
| 104 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.37436197 |
| 105 | positive thymic T cell selection (GO:0045059) | 2.36929158 |
| 106 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.36251540 |
| 107 | protein activation cascade (GO:0072376) | 2.35922026 |
| 108 | response to laminar fluid shear stress (GO:0034616) | 2.34134764 |
| 109 | RNA methylation (GO:0001510) | 2.34117670 |
| 110 | respiratory burst (GO:0045730) | 2.33604293 |
| 111 | positive regulation of interferon-alpha production (GO:0032727) | 2.31857029 |
| 112 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.30093310 |
| 113 | regulation of T cell tolerance induction (GO:0002664) | 2.29732880 |
| 114 | detection of molecule of bacterial origin (GO:0032490) | 2.29407605 |
| 115 | low-density lipoprotein particle clearance (GO:0034383) | 2.29282364 |
| 116 | negative regulation of fibrinolysis (GO:0051918) | 2.28963436 |
| 117 | plasma lipoprotein particle assembly (GO:0034377) | 2.28290804 |
| 118 | protein-lipid complex assembly (GO:0065005) | 2.28051623 |
| 119 | oligosaccharide catabolic process (GO:0009313) | 2.27488602 |
| 120 | dendritic cell chemotaxis (GO:0002407) | 2.27437946 |
| 121 | sequestering of metal ion (GO:0051238) | 2.26545983 |
| 122 | regulation of cholesterol storage (GO:0010885) | 2.26101017 |
| 123 | folic acid metabolic process (GO:0046655) | 2.25988297 |
| 124 | rRNA methylation (GO:0031167) | 2.25960966 |
| 125 | apoptotic cell clearance (GO:0043277) | 2.25867887 |
| 126 | regulation of necrotic cell death (GO:0010939) | 2.25541218 |
| 127 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.25335267 |
| 128 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.24374646 |
| 129 | regulation of interferon-alpha production (GO:0032647) | 2.24091597 |
| 130 | myeloid leukocyte mediated immunity (GO:0002444) | 2.23776641 |
| 131 | superoxide anion generation (GO:0042554) | 2.23479445 |
| 132 | phospholipid efflux (GO:0033700) | 2.23213604 |
| 133 | modulation by symbiont of host cellular process (GO:0044068) | 2.23186168 |
| 134 | positive regulation of extracellular matrix organization (GO:1903055) | 2.23152276 |
| 135 | neutrophil activation involved in immune response (GO:0002283) | 2.22893444 |
| 136 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.22703370 |
| 137 | lymphocyte migration (GO:0072676) | 2.22257597 |
| 138 | telomere maintenance via recombination (GO:0000722) | 2.22206830 |
| 139 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.21535601 |
| 140 | DNA synthesis involved in DNA repair (GO:0000731) | 2.21195797 |
| 141 | complement activation (GO:0006956) | 2.20427410 |
| 142 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.20353464 |
| 143 | protein carboxylation (GO:0018214) | 2.20353464 |
| 144 | negative regulation of phagocytosis (GO:0050765) | 2.20296097 |
| 145 | negative regulation of granulocyte differentiation (GO:0030853) | 2.20117596 |
| 146 | endocrine pancreas development (GO:0031018) | 2.20046942 |
| 147 | mRNA modification (GO:0016556) | 2.19754719 |
| 148 | amyloid precursor protein catabolic process (GO:0042987) | 2.19664106 |
| 149 | dendritic cell differentiation (GO:0097028) | 2.19573151 |
| 150 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.19274418 |
| 151 | response to thyroid hormone (GO:0097066) | 2.19254050 |
| 152 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.19049786 |
| 153 | regulation of antigen processing and presentation (GO:0002577) | 2.18798914 |
| 154 | DNA strand elongation (GO:0022616) | 2.18685594 |
| 155 | regulation of cholesterol esterification (GO:0010872) | 2.18581511 |
| 156 | mitochondrial calcium ion transport (GO:0006851) | 2.17755293 |
| 157 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.17653192 |
| 158 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.17353290 |
| 159 | regulation of leukocyte degranulation (GO:0043300) | 2.16951143 |
| 160 | regulation of B cell apoptotic process (GO:0002902) | 2.16803916 |
| 161 | glycine metabolic process (GO:0006544) | 2.16483553 |
| 162 | nucleotide-sugar metabolic process (GO:0009225) | 2.16472673 |
| 163 | regulation of tolerance induction (GO:0002643) | 2.16315003 |
| 164 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.16130334 |
| 165 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.15781456 |
| 166 | mature B cell differentiation involved in immune response (GO:0002313) | 2.15620099 |
| 167 | tetrahydrofolate metabolic process (GO:0046653) | 2.15224988 |
| 168 | ribosomal small subunit assembly (GO:0000028) | 2.14750515 |
| 169 | N-acetylneuraminate metabolic process (GO:0006054) | 2.14684571 |
| 170 | regulation of B cell proliferation (GO:0030888) | 2.14385892 |
| 171 | membrane lipid catabolic process (GO:0046466) | 2.13600642 |
| 172 | folic acid-containing compound metabolic process (GO:0006760) | 2.12197173 |
| 173 | regulation of superoxide anion generation (GO:0032928) | 2.11844437 |
| 174 | intestinal absorption (GO:0050892) | 2.11751454 |
| 175 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.10892588 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.66256984 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.19706475 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.99108328 |
| 4 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.13147134 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.88663954 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.83207723 |
| 7 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.62202153 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.51389144 |
| 9 | GATA1_22025678_ChIP-Seq_K562_Human | 2.50939314 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.40464373 |
| 11 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.40402904 |
| 12 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.39989125 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.38724492 |
| 14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.36016042 |
| 15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.29745565 |
| 16 | MYC_22102868_ChIP-Seq_BL_Human | 2.26186969 |
| 17 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18730888 |
| 18 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.14540092 |
| 19 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.14281167 |
| 20 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.06927078 |
| 21 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.04747271 |
| 22 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02140689 |
| 23 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.01897230 |
| 24 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.00401712 |
| 25 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.00014692 |
| 26 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.97253396 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.96003726 |
| 28 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.95917093 |
| 29 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.95862469 |
| 30 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.94372176 |
| 31 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.92125813 |
| 32 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.89609728 |
| 33 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.89543951 |
| 34 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.88876092 |
| 35 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.88426102 |
| 36 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.87628513 |
| 37 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.86972107 |
| 38 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.83721843 |
| 39 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.81362379 |
| 40 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.81318706 |
| 41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.81209042 |
| 42 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.80414066 |
| 43 | MYB_26560356_Chip-Seq_TH1_Human | 1.79658673 |
| 44 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.79115494 |
| 45 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.75232300 |
| 46 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.74968138 |
| 47 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73853588 |
| 48 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72768502 |
| 49 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.72317741 |
| 50 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.72168747 |
| 51 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.72027095 |
| 52 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.69866569 |
| 53 | MYB_26560356_Chip-Seq_TH2_Human | 1.68895319 |
| 54 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.67778650 |
| 55 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.65412609 |
| 56 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.62191140 |
| 57 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.61751239 |
| 58 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.60552821 |
| 59 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58555513 |
| 60 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.57845647 |
| 61 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.56991656 |
| 62 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.56680928 |
| 63 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.56354767 |
| 64 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.55678058 |
| 65 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.54445666 |
| 66 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53256462 |
| 67 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.53010791 |
| 68 | SPI1_23127762_ChIP-Seq_K562_Human | 1.52752207 |
| 69 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.52275362 |
| 70 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.51417752 |
| 71 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.50927051 |
| 72 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.50555722 |
| 73 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.49788566 |
| 74 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.48298365 |
| 75 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.47687045 |
| 76 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.46930848 |
| 77 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.46033136 |
| 78 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.43702505 |
| 79 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.42281354 |
| 80 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.42083968 |
| 81 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.41751397 |
| 82 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.41408793 |
| 83 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.41307743 |
| 84 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40822447 |
| 85 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.39942634 |
| 86 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.38631643 |
| 87 | GATA1_19941826_ChIP-Seq_K562_Human | 1.37990526 |
| 88 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.37902400 |
| 89 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.36118913 |
| 90 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.35982322 |
| 91 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.35537406 |
| 92 | MAF_26560356_Chip-Seq_TH1_Human | 1.33613714 |
| 93 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.32477244 |
| 94 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.31331507 |
| 95 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.31286933 |
| 96 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.31040588 |
| 97 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.30307471 |
| 98 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.29896713 |
| 99 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29332284 |
| 100 | UTX_26944678_Chip-Seq_JUKART_Human | 1.29242402 |
| 101 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27606489 |
| 102 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.26374430 |
| 103 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.25623794 |
| 104 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.25495327 |
| 105 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.22569448 |
| 106 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20556247 |
| 107 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.20129489 |
| 108 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20017641 |
| 109 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.18891463 |
| 110 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17949420 |
| 111 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.17012622 |
| 112 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.16854642 |
| 113 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.16679047 |
| 114 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16228905 |
| 115 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.15884688 |
| 116 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.14973306 |
| 117 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.14534455 |
| 118 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.13681851 |
| 119 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.12493791 |
| 120 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12235369 |
| 121 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.09793601 |
| 122 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09086943 |
| 123 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.07393593 |
| 124 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07350188 |
| 125 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.06572793 |
| 126 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.05900357 |
| 127 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.05505721 |
| 128 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.04630903 |
| 129 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04516760 |
| 130 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.03548878 |
| 131 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02480012 |
| 132 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.02366382 |
| 133 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.01838688 |
| 134 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.01706934 |
| 135 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00787207 |
| 136 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.00580280 |
| 137 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.00069091 |
| 138 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99847985 |
| 139 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.99314059 |
| 140 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.98428987 |
| 141 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.97874302 |
| 142 | MAF_26560356_Chip-Seq_TH2_Human | 0.97844680 |
| 143 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.97280255 |
| 144 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.97166920 |
| 145 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.96426290 |
| 146 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.96397126 |
| 147 | KDM2B_26808549_Chip-Seq_K562_Human | 0.96196546 |
| 148 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.95897782 |
| 149 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.95333917 |
| 150 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.91855552 |
| 151 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91558797 |
| 152 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89118560 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 3.04328255 |
| 2 | MP0001835_abnormal_antigen_presentation | 2.94712109 |
| 3 | MP0005058_abnormal_lysosome_morphology | 2.88914056 |
| 4 | MP0005365_abnormal_bile_salt | 2.82153190 |
| 5 | MP0005220_abnormal_exocrine_pancreas | 2.76789535 |
| 6 | MP0001666_abnormal_nutrient_absorption | 2.75720620 |
| 7 | MP0005451_abnormal_body_composition | 2.51434952 |
| 8 | MP0001800_abnormal_humoral_immune | 2.44993124 |
| 9 | MP0005387_immune_system_phenotype | 2.10838149 |
| 10 | MP0001790_abnormal_immune_system | 2.10838149 |
| 11 | MP0004264_abnormal_extraembryonic_tissu | 2.08616909 |
| 12 | MP0005083_abnormal_biliary_tract | 2.07721824 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.06716740 |
| 14 | MP0003172_abnormal_lysosome_physiology | 2.05597977 |
| 15 | MP0003436_decreased_susceptibility_to | 1.97777245 |
| 16 | MP0002693_abnormal_pancreas_physiology | 1.97456600 |
| 17 | MP0005671_abnormal_response_to | 1.97102704 |
| 18 | MP0002396_abnormal_hematopoietic_system | 1.97086775 |
| 19 | MP0003763_abnormal_thymus_physiology | 1.95838125 |
| 20 | MP0002723_abnormal_immune_serum | 1.91124614 |
| 21 | MP0005000_abnormal_immune_tolerance | 1.82771163 |
| 22 | MP0002139_abnormal_hepatobiliary_system | 1.82217184 |
| 23 | MP0002420_abnormal_adaptive_immunity | 1.81860800 |
| 24 | MP0003868_abnormal_feces_composition | 1.81057099 |
| 25 | MP0000490_abnormal_crypts_of | 1.81014514 |
| 26 | MP0001819_abnormal_immune_cell | 1.79262076 |
| 27 | MP0001873_stomach_inflammation | 1.77708425 |
| 28 | MP0002398_abnormal_bone_marrow | 1.75562016 |
| 29 | MP0002419_abnormal_innate_immunity | 1.74553822 |
| 30 | MP0000685_abnormal_immune_system | 1.69590005 |
| 31 | MP0000689_abnormal_spleen_morphology | 1.67814927 |
| 32 | MP0009785_altered_susceptibility_to | 1.64777263 |
| 33 | MP0005025_abnormal_response_to | 1.64036784 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.63656923 |
| 35 | MP0008058_abnormal_DNA_repair | 1.62949225 |
| 36 | MP0000716_abnormal_immune_system | 1.62571071 |
| 37 | MP0001853_heart_inflammation | 1.62208627 |
| 38 | MP0005085_abnormal_gallbladder_physiolo | 1.58059988 |
| 39 | MP0006082_CNS_inflammation | 1.56386964 |
| 40 | MP0001845_abnormal_inflammatory_respons | 1.56092017 |
| 41 | MP0001944_abnormal_pancreas_morphology | 1.50472191 |
| 42 | MP0003111_abnormal_nucleus_morphology | 1.49523370 |
| 43 | MP0002722_abnormal_immune_system | 1.49440882 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.48479586 |
| 45 | MP0002138_abnormal_hepatobiliary_system | 1.47271737 |
| 46 | MP0003252_abnormal_bile_duct | 1.47045812 |
| 47 | MP0010094_abnormal_chromosome_stability | 1.46812140 |
| 48 | MP0002429_abnormal_blood_cell | 1.42987721 |
| 49 | MP0002166_altered_tumor_susceptibility | 1.42727190 |
| 50 | MP0002405_respiratory_system_inflammati | 1.40547407 |
| 51 | MP0005084_abnormal_gallbladder_morpholo | 1.40453972 |
| 52 | MP0005464_abnormal_platelet_physiology | 1.39834027 |
| 53 | MP0004808_abnormal_hematopoietic_stem | 1.37307751 |
| 54 | MP0002148_abnormal_hypersensitivity_rea | 1.37156294 |
| 55 | MP0006054_spinal_hemorrhage | 1.36192178 |
| 56 | MP0000703_abnormal_thymus_morphology | 1.34908664 |
| 57 | MP0002998_abnormal_bone_remodeling | 1.34858121 |
| 58 | MP0008260_abnormal_autophagy | 1.34854995 |
| 59 | MP0003724_increased_susceptibility_to | 1.34222366 |
| 60 | MP0000604_amyloidosis | 1.31277947 |
| 61 | MP0005360_urolithiasis | 1.28428880 |
| 62 | MP0010234_abnormal_vibrissa_follicle | 1.26795859 |
| 63 | MP0005174_abnormal_tail_pigmentation | 1.25647620 |
| 64 | MP0003303_peritoneal_inflammation | 1.24999600 |
| 65 | MP0002006_tumorigenesis | 1.23957575 |
| 66 | MP0003075_altered_response_to | 1.22541922 |
| 67 | MP0008469_abnormal_protein_level | 1.21085439 |
| 68 | MP0004510_myositis | 1.20706972 |
| 69 | MP0009643_abnormal_urine_homeostasis | 1.17783573 |
| 70 | MP0009840_abnormal_foam_cell | 1.16221565 |
| 71 | MP0005076_abnormal_cell_differentiation | 1.16166993 |
| 72 | MP0008004_abnormal_stomach_pH | 1.15951795 |
| 73 | MP0008057_abnormal_DNA_replication | 1.15707946 |
| 74 | MP0000371_diluted_coat_color | 1.15682809 |
| 75 | MP0003300_gastrointestinal_ulcer | 1.14662167 |
| 76 | MP0003453_abnormal_keratinocyte_physiol | 1.14620070 |
| 77 | MP0003077_abnormal_cell_cycle | 1.14338405 |
| 78 | MP0005670_abnormal_white_adipose | 1.14037921 |
| 79 | MP0003195_calcinosis | 1.13572465 |
| 80 | MP0005075_abnormal_melanosome_morpholog | 1.13566130 |
| 81 | MP0003091_abnormal_cell_migration | 1.13543672 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 1.13359353 |
| 83 | MP0009278_abnormal_bone_marrow | 1.12081739 |
| 84 | MP0009764_decreased_sensitivity_to | 1.11555932 |
| 85 | MP0000465_gastrointestinal_hemorrhage | 1.10580949 |
| 86 | MP0002277_abnormal_respiratory_mucosa | 1.10031698 |
| 87 | MP0002876_abnormal_thyroid_physiology | 1.09927093 |
| 88 | MP0002019_abnormal_tumor_incidence | 1.07391904 |
| 89 | MP0000566_synostosis | 1.06296449 |
| 90 | MP0005166_decreased_susceptibility_to | 1.06095874 |
| 91 | MP0001986_abnormal_taste_sensitivity | 1.04091515 |
| 92 | MP0002132_abnormal_respiratory_system | 1.03937815 |
| 93 | MP0006292_abnormal_olfactory_placode | 1.03178332 |
| 94 | MP0000609_abnormal_liver_physiology | 1.02601793 |
| 95 | MP0000858_altered_metastatic_potential | 1.00876531 |
| 96 | MP0000613_abnormal_salivary_gland | 0.99988608 |
| 97 | MP0000015_abnormal_ear_pigmentation | 0.99314355 |
| 98 | MP0003191_abnormal_cellular_cholesterol | 0.98851516 |
| 99 | MP0001545_abnormal_hematopoietic_system | 0.97370121 |
| 100 | MP0005397_hematopoietic_system_phenotyp | 0.97370121 |
| 101 | MP0005310_abnormal_salivary_gland | 0.95544410 |
| 102 | MP0003828_pulmonary_edema | 0.93783332 |
| 103 | MP0003866_abnormal_defecation | 0.93494784 |
| 104 | MP0002933_joint_inflammation | 0.92817958 |
| 105 | MP0003186_abnormal_redox_activity | 0.91056868 |
| 106 | MP0004782_abnormal_surfactant_physiolog | 0.90432798 |
| 107 | MP0005164_abnormal_response_to | 0.89177995 |
| 108 | MP0008438_abnormal_cutaneous_collagen | 0.88665355 |
| 109 | MP0001764_abnormal_homeostasis | 0.88462238 |
| 110 | MP0003183_abnormal_peptide_metabolism | 0.88251651 |
| 111 | MP0003566_abnormal_cell_adhesion | 0.87884773 |
| 112 | MP0004947_skin_inflammation | 0.87601539 |
| 113 | MP0008007_abnormal_cellular_replicative | 0.87600819 |
| 114 | MP0000343_altered_response_to | 0.87314836 |
| 115 | MP0005023_abnormal_wound_healing | 0.86728775 |
| 116 | MP0002136_abnormal_kidney_physiology | 0.86061209 |
| 117 | MP0004381_abnormal_hair_follicle | 0.85173342 |
| 118 | MP0001919_abnormal_reproductive_system | 0.83759764 |
| 119 | MP0001663_abnormal_digestive_system | 0.83706393 |
| 120 | MP0001851_eye_inflammation | 0.82650177 |
| 121 | MP0002877_abnormal_melanocyte_morpholog | 0.82377175 |
| 122 | MP0004957_abnormal_blastocyst_morpholog | 0.82196818 |
| 123 | MP0005332_abnormal_amino_acid | 0.81409214 |
| 124 | MP0001533_abnormal_skeleton_physiology | 0.81283786 |
| 125 | MP0000598_abnormal_liver_morphology | 0.80577374 |
| 126 | MP0010329_abnormal_lipoprotein_level | 0.80290132 |
| 127 | MP0002928_abnormal_bile_duct | 0.79169547 |
| 128 | MP0003329_amyloid_beta_deposits | 0.78469571 |
| 129 | MP0009763_increased_sensitivity_to | 0.77869332 |
| 130 | MP0001186_pigmentation_phenotype | 0.77783587 |
| 131 | MP0002118_abnormal_lipid_homeostasis | 0.77736353 |
| 132 | MP0000249_abnormal_blood_vessel | 0.76945239 |
| 133 | MP0003045_fibrosis | 0.76467135 |
| 134 | MP0003448_altered_tumor_morphology | 0.75101012 |
| 135 | MP0005389_reproductive_system_phenotype | 0.74939162 |
| 136 | MP0005319_abnormal_enzyme/_coenzyme | 0.74214731 |
| 137 | MP0003705_abnormal_hypodermis_morpholog | 0.73975665 |
| 138 | MP0003806_abnormal_nucleotide_metabolis | 0.73759242 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of B cell number (HP:0010975) | 4.70572602 |
| 2 | B lymphocytopenia (HP:0010976) | 4.70572602 |
| 3 | Agammaglobulinemia (HP:0004432) | 4.25125448 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 3.73338713 |
| 5 | Recurrent viral infections (HP:0004429) | 3.70221820 |
| 6 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.61022711 |
| 7 | IgM deficiency (HP:0002850) | 3.56484433 |
| 8 | Colitis (HP:0002583) | 3.54432380 |
| 9 | Reduced antithrombin III activity (HP:0001976) | 3.43378629 |
| 10 | Dysostosis multiplex (HP:0000943) | 3.42504317 |
| 11 | Abnormality of glycolipid metabolism (HP:0010969) | 3.41837861 |
| 12 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.41837861 |
| 13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.41837861 |
| 14 | Chromsome breakage (HP:0040012) | 3.28989937 |
| 15 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.27676746 |
| 16 | Meningitis (HP:0001287) | 3.22563025 |
| 17 | Inflammation of the large intestine (HP:0002037) | 3.20017057 |
| 18 | Deep venous thrombosis (HP:0002625) | 3.18077451 |
| 19 | Type I transferrin isoform profile (HP:0003642) | 3.13307799 |
| 20 | Gastrointestinal inflammation (HP:0004386) | 3.12602937 |
| 21 | Vacuolated lymphocytes (HP:0001922) | 3.00443593 |
| 22 | Granulocytopenia (HP:0001913) | 2.90191932 |
| 23 | Abnormality of T cell physiology (HP:0011840) | 2.87965793 |
| 24 | Panhypogammaglobulinemia (HP:0003139) | 2.87574380 |
| 25 | Abnormal protein glycosylation (HP:0012346) | 2.84674153 |
| 26 | Abnormal glycosylation (HP:0012345) | 2.84674153 |
| 27 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.84674153 |
| 28 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.84674153 |
| 29 | Complement deficiency (HP:0004431) | 2.84637587 |
| 30 | Gastrointestinal stroma tumor (HP:0100723) | 2.81326720 |
| 31 | Vasculitis (HP:0002633) | 2.77423137 |
| 32 | Glomerulonephritis (HP:0000099) | 2.75616724 |
| 33 | Recurrent sinusitis (HP:0011108) | 2.75196913 |
| 34 | Cellulitis (HP:0100658) | 2.74732464 |
| 35 | Recurrent fungal infections (HP:0002841) | 2.74381271 |
| 36 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.72887230 |
| 37 | Abnormality of complement system (HP:0005339) | 2.71671774 |
| 38 | Recurrent abscess formation (HP:0002722) | 2.67538114 |
| 39 | Thyroiditis (HP:0100646) | 2.64763232 |
| 40 | Recurrent bronchitis (HP:0002837) | 2.62851152 |
| 41 | Purpura (HP:0000979) | 2.62038830 |
| 42 | Obstructive lung disease (HP:0006536) | 2.60003091 |
| 43 | Chronic obstructive pulmonary disease (HP:0006510) | 2.60003091 |
| 44 | Malnutrition (HP:0004395) | 2.57149386 |
| 45 | Loss of speech (HP:0002371) | 2.53738759 |
| 46 | Recurrent pneumonia (HP:0006532) | 2.53558791 |
| 47 | Increased cerebral lipofuscin (HP:0011813) | 2.51955897 |
| 48 | Recurrent bacterial skin infections (HP:0005406) | 2.50572739 |
| 49 | Myositis (HP:0100614) | 2.49954682 |
| 50 | Abnormality of the common coagulation pathway (HP:0010990) | 2.48412283 |
| 51 | Reticulocytopenia (HP:0001896) | 2.47514840 |
| 52 | Abnormality of the intrinsic pathway (HP:0010989) | 2.45390265 |
| 53 | Hemorrhage of the eye (HP:0011885) | 2.44209063 |
| 54 | Abnormality of T cells (HP:0002843) | 2.43206156 |
| 55 | Orchitis (HP:0100796) | 2.41792549 |
| 56 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.41532323 |
| 57 | Severe combined immunodeficiency (HP:0004430) | 2.39582383 |
| 58 | Mediastinal lymphadenopathy (HP:0100721) | 2.39065351 |
| 59 | Gastrointestinal infarctions (HP:0005244) | 2.38085359 |
| 60 | Gingival bleeding (HP:0000225) | 2.37034079 |
| 61 | Nuclear cataract (HP:0100018) | 2.36350770 |
| 62 | Hypoglycemic coma (HP:0001325) | 2.35495705 |
| 63 | Eczematoid dermatitis (HP:0000976) | 2.35265935 |
| 64 | Hypoproteinemia (HP:0003075) | 2.32244285 |
| 65 | Duplicated collecting system (HP:0000081) | 2.31945850 |
| 66 | Recurrent cutaneous fungal infections (HP:0011370) | 2.31149792 |
| 67 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.31149792 |
| 68 | Hypoglycemic seizures (HP:0002173) | 2.30000706 |
| 69 | Flat acetabular roof (HP:0003180) | 2.27537405 |
| 70 | Asymmetric septal hypertrophy (HP:0001670) | 2.26840850 |
| 71 | Hyperactive renin-angiotensin system (HP:0000841) | 2.25614535 |
| 72 | Osteomyelitis (HP:0002754) | 2.25562488 |
| 73 | Emphysema (HP:0002097) | 2.25324220 |
| 74 | Abnormality of the fingertips (HP:0001211) | 2.24848179 |
| 75 | Interstitial pulmonary disease (HP:0006530) | 2.23642636 |
| 76 | Recurrent lower respiratory tract infections (HP:0002783) | 2.23117475 |
| 77 | Spontaneous hematomas (HP:0007420) | 2.22657571 |
| 78 | Increased serum ferritin (HP:0003281) | 2.21958295 |
| 79 | Eosinophilia (HP:0001880) | 2.21660991 |
| 80 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.21038833 |
| 81 | Abnormality of chromosome stability (HP:0003220) | 2.18939661 |
| 82 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.17502755 |
| 83 | Xanthomatosis (HP:0000991) | 2.17251067 |
| 84 | IgA deficiency (HP:0002720) | 2.16927620 |
| 85 | Proximal tubulopathy (HP:0000114) | 2.16075614 |
| 86 | Nephritis (HP:0000123) | 2.15838625 |
| 87 | Vertebral compression fractures (HP:0002953) | 2.13827528 |
| 88 | Clubbing of toes (HP:0100760) | 2.13181407 |
| 89 | Chronic diarrhea (HP:0002028) | 2.13105486 |
| 90 | Urticaria (HP:0001025) | 2.12049072 |
| 91 | Pustule (HP:0200039) | 2.11914489 |
| 92 | Increased IgE level (HP:0003212) | 2.11804434 |
| 93 | Retrobulbar optic neuritis (HP:0100654) | 2.11591480 |
| 94 | Optic neuritis (HP:0100653) | 2.11591480 |
| 95 | Epistaxis (HP:0000421) | 2.11454892 |
| 96 | Abnormality of the renal collecting system (HP:0004742) | 2.09573844 |
| 97 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.08322320 |
| 98 | Hypertensive crisis (HP:0100735) | 2.08254576 |
| 99 | Acute lymphatic leukemia (HP:0006721) | 2.08128602 |
| 100 | IgG deficiency (HP:0004315) | 2.07627344 |
| 101 | Autoimmune thrombocytopenia (HP:0001973) | 2.07387264 |
| 102 | Neutropenia (HP:0001875) | 2.06025727 |
| 103 | T lymphocytopenia (HP:0005403) | 2.05561723 |
| 104 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.05288495 |
| 105 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.05288495 |
| 106 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.05288495 |
| 107 | Abnormality of macrophages (HP:0004311) | 2.04183972 |
| 108 | Leukopenia (HP:0001882) | 2.03513719 |
| 109 | Combined immunodeficiency (HP:0005387) | 2.03026867 |
| 110 | Papilloma (HP:0012740) | 2.02525421 |
| 111 | Verrucae (HP:0200043) | 2.02525421 |
| 112 | Amyloidosis (HP:0011034) | 2.02348144 |
| 113 | Thrombocytosis (HP:0001894) | 2.00497191 |
| 114 | Recurrent skin infections (HP:0001581) | 1.99087990 |
| 115 | Restrictive lung disease (HP:0002091) | 1.98906903 |
| 116 | Joint hemorrhage (HP:0005261) | 1.98884326 |
| 117 | Bone marrow hypocellularity (HP:0005528) | 1.98788071 |
| 118 | Premature loss of primary teeth (HP:0006323) | 1.98321223 |
| 119 | Mucopolysacchariduria (HP:0008155) | 1.97647938 |
| 120 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.97647938 |
| 121 | Symptomatic seizures (HP:0011145) | 1.97453507 |
| 122 | Conjugated hyperbilirubinemia (HP:0002908) | 1.97428938 |
| 123 | Lymphopenia (HP:0001888) | 1.97340512 |
| 124 | Autoimmune hemolytic anemia (HP:0001890) | 1.97018485 |
| 125 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.95839242 |
| 126 | Hypoplasia of the thymus (HP:0000778) | 1.94795382 |
| 127 | Abnormality of the preputium (HP:0100587) | 1.93998083 |
| 128 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.93590199 |
| 129 | Lymphoma (HP:0002665) | 1.92687700 |
| 130 | Chronic otitis media (HP:0000389) | 1.90838572 |
| 131 | Sepsis (HP:0100806) | 1.89861246 |
| 132 | Hypophosphatemia (HP:0002148) | 1.89779105 |
| 133 | Abnormality of T cell number (HP:0011839) | 1.89411236 |
| 134 | Seborrheic dermatitis (HP:0001051) | 1.89298111 |
| 135 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.88417789 |
| 136 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.88417789 |
| 137 | Fatigue (HP:0012378) | 1.88026420 |
| 138 | Meckel diverticulum (HP:0002245) | 1.87933443 |
| 139 | Prolonged partial thromboplastin time (HP:0003645) | 1.87742571 |
| 140 | Abnormality of eosinophils (HP:0001879) | 1.86662273 |
| 141 | Ovoid vertebral bodies (HP:0003300) | 1.85785766 |
| 142 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.85426931 |
| 143 | Thin bony cortex (HP:0002753) | 1.85130381 |
| 144 | Petechiae (HP:0000967) | 1.84433314 |
| 145 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.83591329 |
| 146 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.82566865 |
| 147 | Periodontitis (HP:0000704) | 1.82428224 |
| 148 | Abnormality of iron homeostasis (HP:0011031) | 1.81451864 |
| 149 | Bronchitis (HP:0012387) | 1.79932994 |
| 150 | Thoracic kyphosis (HP:0002942) | 1.79806422 |
| 151 | Gingivitis (HP:0000230) | 1.79063708 |
| 152 | Generalized aminoaciduria (HP:0002909) | 1.77205910 |
| 153 | Pulmonary infiltrates (HP:0002113) | 1.76912280 |
| 154 | Aplastic anemia (HP:0001915) | 1.75407237 |
| 155 | Abnormality of the ileum (HP:0001549) | 1.74541149 |
| 156 | Hypergammaglobulinemia (HP:0010702) | 1.73972764 |
| 157 | Prolonged bleeding time (HP:0003010) | 1.73751072 |
| 158 | Decreased circulating renin level (HP:0003351) | 1.73686311 |
| 159 | Encephalitis (HP:0002383) | 1.73038413 |
| 160 | Renal cortical cysts (HP:0000803) | 1.72776548 |
| 161 | Cheilitis (HP:0100825) | 1.72340869 |
| 162 | Hemoptysis (HP:0002105) | 1.71753784 |
| 163 | Myocardial infarction (HP:0001658) | 1.71636275 |
| 164 | Joint swelling (HP:0001386) | 1.71170929 |
| 165 | Pulmonary embolism (HP:0002204) | 1.70906062 |
| 166 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.70554300 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 5.39984653 |
| 2 | ERN1 | 3.96028526 |
| 3 | PRPF4B | 3.81151700 |
| 4 | IRAK4 | 3.72307402 |
| 5 | MAP3K10 | 3.02599852 |
| 6 | TAOK3 | 2.76236052 |
| 7 | MAP4K1 | 2.65333673 |
| 8 | TRIB3 | 2.59462787 |
| 9 | INSRR | 2.50375744 |
| 10 | EIF2AK3 | 2.42117321 |
| 11 | PLK4 | 2.39452846 |
| 12 | ZAK | 2.29391669 |
| 13 | STK16 | 2.20072603 |
| 14 | BLK | 2.00901599 |
| 15 | IRAK1 | 1.94136105 |
| 16 | MAP3K14 | 1.84469007 |
| 17 | BCKDK | 1.83978596 |
| 18 | CDK12 | 1.77342853 |
| 19 | IRAK2 | 1.74317787 |
| 20 | RIPK1 | 1.73411720 |
| 21 | ICK | 1.58123750 |
| 22 | BTK | 1.49050969 |
| 23 | BRD4 | 1.48846994 |
| 24 | NME2 | 1.45436656 |
| 25 | SRPK1 | 1.43016923 |
| 26 | TEC | 1.41061395 |
| 27 | FGFR3 | 1.40599789 |
| 28 | CDC42BPA | 1.37763945 |
| 29 | TYK2 | 1.37638611 |
| 30 | JAK3 | 1.33308819 |
| 31 | TLK1 | 1.32586263 |
| 32 | ZAP70 | 1.31440315 |
| 33 | SMG1 | 1.28814940 |
| 34 | MAP3K1 | 1.27706302 |
| 35 | TAOK2 | 1.27106490 |
| 36 | FLT3 | 1.24409108 |
| 37 | TXK | 1.23546847 |
| 38 | SIK1 | 1.22101237 |
| 39 | IKBKB | 1.17806895 |
| 40 | MAP3K11 | 1.15723086 |
| 41 | IKBKE | 1.14249054 |
| 42 | PRKD2 | 1.11845010 |
| 43 | TAOK1 | 1.08712481 |
| 44 | SYK | 1.08329044 |
| 45 | GRK6 | 1.06096038 |
| 46 | SCYL2 | 1.05361353 |
| 47 | EIF2AK2 | 1.04933887 |
| 48 | PASK | 1.03000921 |
| 49 | TBK1 | 1.02042842 |
| 50 | MATK | 1.01579979 |
| 51 | MAPK15 | 1.00995779 |
| 52 | NLK | 1.00428610 |
| 53 | EPHA2 | 0.99883259 |
| 54 | PDPK1 | 0.99178313 |
| 55 | NUAK1 | 0.96220046 |
| 56 | NEK9 | 0.94765744 |
| 57 | PIM1 | 0.94718355 |
| 58 | CHUK | 0.94135787 |
| 59 | ATR | 0.93362853 |
| 60 | LYN | 0.93253612 |
| 61 | FRK | 0.91997543 |
| 62 | RPS6KB2 | 0.91425859 |
| 63 | BUB1 | 0.90137469 |
| 64 | JAK1 | 0.89375961 |
| 65 | PDK1 | 0.89223336 |
| 66 | CSF1R | 0.88924014 |
| 67 | MARK2 | 0.88600135 |
| 68 | KDR | 0.87737201 |
| 69 | MAP2K3 | 0.86954462 |
| 70 | MAPKAPK3 | 0.86486540 |
| 71 | EPHB1 | 0.86273494 |
| 72 | HIPK2 | 0.80737611 |
| 73 | DYRK3 | 0.79690902 |
| 74 | STK4 | 0.78580913 |
| 75 | JAK2 | 0.78453364 |
| 76 | TRPM7 | 0.75617746 |
| 77 | NEK2 | 0.75008542 |
| 78 | PIK3CG | 0.74687171 |
| 79 | LATS1 | 0.74183960 |
| 80 | MAP2K2 | 0.73892478 |
| 81 | TTK | 0.71394043 |
| 82 | TNK2 | 0.71222370 |
| 83 | AKT3 | 0.70611898 |
| 84 | KIT | 0.69206719 |
| 85 | KSR2 | 0.68492310 |
| 86 | MAP3K6 | 0.67184560 |
| 87 | MAPK12 | 0.67112617 |
| 88 | SIK3 | 0.64889673 |
| 89 | PRKCI | 0.64352465 |
| 90 | GRK1 | 0.64186824 |
| 91 | TESK2 | 0.64024678 |
| 92 | CDK4 | 0.63465441 |
| 93 | BMPR2 | 0.62247800 |
| 94 | PDGFRA | 0.61532929 |
| 95 | PIM2 | 0.60917772 |
| 96 | PTK6 | 0.60579113 |
| 97 | DDR2 | 0.60150843 |
| 98 | CDC7 | 0.59939414 |
| 99 | SIK2 | 0.59828865 |
| 100 | STK10 | 0.59155518 |
| 101 | VRK1 | 0.58501524 |
| 102 | EEF2K | 0.57716425 |
| 103 | MAP3K13 | 0.56787393 |
| 104 | RET | 0.56020608 |
| 105 | RIPK4 | 0.55820170 |
| 106 | FGR | 0.55477865 |
| 107 | CSK | 0.54432725 |
| 108 | RPS6KC1 | 0.53944781 |
| 109 | RPS6KL1 | 0.53944781 |
| 110 | STK24 | 0.53177340 |
| 111 | MTOR | 0.52941330 |
| 112 | FGFR4 | 0.52806603 |
| 113 | LCK | 0.52774208 |
| 114 | MKNK2 | 0.52448982 |
| 115 | ITK | 0.51841391 |
| 116 | MAP3K2 | 0.51819224 |
| 117 | ARAF | 0.51717166 |
| 118 | RPS6KA4 | 0.51604783 |
| 119 | SGK3 | 0.51435341 |
| 120 | TTN | 0.51113512 |
| 121 | MST1R | 0.49515272 |
| 122 | PDK2 | 0.48899293 |
| 123 | RPS6KA2 | 0.46312307 |
| 124 | CHEK2 | 0.46305549 |
| 125 | HCK | 0.46141880 |
| 126 | YES1 | 0.46022065 |
| 127 | ADRBK2 | 0.44504820 |
| 128 | EPHA3 | 0.44302931 |
| 129 | WEE1 | 0.43831849 |
| 130 | TGFBR2 | 0.43579353 |
| 131 | MAPK7 | 0.42873562 |
| 132 | CDK7 | 0.42375317 |
| 133 | FES | 0.41875055 |
| 134 | MAP2K6 | 0.41774483 |
| 135 | PRKAA2 | 0.41694918 |
| 136 | LRRK2 | 0.41454959 |
| 137 | CDK6 | 0.41220693 |
| 138 | RPS6KA6 | 0.39940428 |
| 139 | AURKB | 0.38064124 |
| 140 | CDK9 | 0.35957635 |
| 141 | MAP3K8 | 0.35616708 |
| 142 | MARK3 | 0.35427249 |
| 143 | PLK1 | 0.34307604 |
| 144 | PKN2 | 0.33332095 |
| 145 | MAP3K3 | 0.30373171 |
| 146 | MAPK11 | 0.27467902 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 3.63620525 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.26622429 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.65742296 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.53033881 |
| 5 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.44337677 |
| 6 | DNA replication_Homo sapiens_hsa03030 | 2.37227599 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.25013971 |
| 8 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.13682100 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.08842699 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.05539202 |
| 11 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.98283283 |
| 12 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.96420253 |
| 13 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.94284782 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.80982272 |
| 15 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.78218075 |
| 16 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.76649468 |
| 17 | Homologous recombination_Homo sapiens_hsa03440 | 1.70954559 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.69486239 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.67288206 |
| 20 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.62004536 |
| 21 | Base excision repair_Homo sapiens_hsa03410 | 1.61836876 |
| 22 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.60496822 |
| 23 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.59280926 |
| 24 | Mismatch repair_Homo sapiens_hsa03430 | 1.53424303 |
| 25 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.53190853 |
| 26 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.51178864 |
| 27 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.49500099 |
| 28 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.49214276 |
| 29 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.39669057 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.29666391 |
| 31 | Leishmaniasis_Homo sapiens_hsa05140 | 1.28990700 |
| 32 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.28662674 |
| 33 | Measles_Homo sapiens_hsa05162 | 1.27189560 |
| 34 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.26799843 |
| 35 | Viral myocarditis_Homo sapiens_hsa05416 | 1.26277068 |
| 36 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.22758638 |
| 37 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.21331805 |
| 38 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.18716904 |
| 39 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.17774437 |
| 40 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.13474074 |
| 41 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.10013372 |
| 42 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.09214227 |
| 43 | Ribosome_Homo sapiens_hsa03010 | 1.08415983 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.02591043 |
| 45 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.01449845 |
| 46 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.01193762 |
| 47 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.00900763 |
| 48 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.00732908 |
| 49 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.00672814 |
| 50 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.00611120 |
| 51 | Legionellosis_Homo sapiens_hsa05134 | 1.00347085 |
| 52 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.00077252 |
| 53 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.99982638 |
| 54 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.98439207 |
| 55 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.98320349 |
| 56 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.98283484 |
| 57 | Influenza A_Homo sapiens_hsa05164 | 0.97918844 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.94429254 |
| 59 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.94157967 |
| 60 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.92911583 |
| 61 | RNA polymerase_Homo sapiens_hsa03020 | 0.91724254 |
| 62 | Malaria_Homo sapiens_hsa05144 | 0.90648889 |
| 63 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.90430577 |
| 64 | Prion diseases_Homo sapiens_hsa05020 | 0.90206120 |
| 65 | Spliceosome_Homo sapiens_hsa03040 | 0.85350777 |
| 66 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.85297250 |
| 67 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85276152 |
| 68 | Sulfur relay system_Homo sapiens_hsa04122 | 0.85061763 |
| 69 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.84866646 |
| 70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.84189978 |
| 71 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.84172771 |
| 72 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.82511752 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.81869163 |
| 74 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.81574169 |
| 75 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.80067837 |
| 76 | Phagosome_Homo sapiens_hsa04145 | 0.79855802 |
| 77 | ABC transporters_Homo sapiens_hsa02010 | 0.79398707 |
| 78 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.76351559 |
| 79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75115914 |
| 80 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.74940869 |
| 81 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.74194728 |
| 82 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.73005528 |
| 83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70685990 |
| 84 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.69772898 |
| 85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.69566932 |
| 86 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.69546597 |
| 87 | Bladder cancer_Homo sapiens_hsa05219 | 0.69348086 |
| 88 | Apoptosis_Homo sapiens_hsa04210 | 0.68806490 |
| 89 | Galactose metabolism_Homo sapiens_hsa00052 | 0.67988204 |
| 90 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.67986909 |
| 91 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.67237793 |
| 92 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.65984952 |
| 93 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.65315118 |
| 94 | Amoebiasis_Homo sapiens_hsa05146 | 0.65186331 |
| 95 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.65114802 |
| 96 | Purine metabolism_Homo sapiens_hsa00230 | 0.64831538 |
| 97 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.64554311 |
| 98 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.63287900 |
| 99 | Pertussis_Homo sapiens_hsa05133 | 0.63284383 |
| 100 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.62698978 |
| 101 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.62290477 |
| 102 | RNA degradation_Homo sapiens_hsa03018 | 0.62107621 |
| 103 | Histidine metabolism_Homo sapiens_hsa00340 | 0.60334310 |
| 104 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.60071965 |
| 105 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.59454696 |
| 106 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.58623711 |
| 107 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58245489 |
| 108 | Lysosome_Homo sapiens_hsa04142 | 0.58235359 |
| 109 | Cell cycle_Homo sapiens_hsa04110 | 0.58130262 |
| 110 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.57963299 |
| 111 | Asthma_Homo sapiens_hsa05310 | 0.57579539 |
| 112 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.57500706 |
| 113 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.56603983 |
| 114 | Hepatitis B_Homo sapiens_hsa05161 | 0.56250792 |
| 115 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.56157040 |
| 116 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.55848210 |
| 117 | Platelet activation_Homo sapiens_hsa04611 | 0.54849502 |
| 118 | Shigellosis_Homo sapiens_hsa05131 | 0.53803210 |
| 119 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.53457576 |
| 120 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.51690037 |
| 121 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51453907 |
| 122 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.51206819 |
| 123 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50795955 |
| 124 | Salmonella infection_Homo sapiens_hsa05132 | 0.50289826 |
| 125 | Hepatitis C_Homo sapiens_hsa05160 | 0.50131608 |
| 126 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.49732116 |
| 127 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48164629 |
| 128 | Tuberculosis_Homo sapiens_hsa05152 | 0.47832292 |
| 129 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.46604974 |
| 130 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46532828 |
| 131 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46508536 |
| 132 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46217789 |
| 133 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.45927412 |
| 134 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.45856535 |
| 135 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.45401345 |
| 136 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.44005052 |
| 137 | Peroxisome_Homo sapiens_hsa04146 | 0.43774737 |
| 138 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.43490889 |
| 139 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.42604959 |
| 140 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.42510021 |
| 141 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.42237462 |
| 142 | HTLV-I infection_Homo sapiens_hsa05166 | 0.42059263 |
| 143 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.41589951 |
| 144 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.40666731 |
| 145 | Prostate cancer_Homo sapiens_hsa05215 | 0.40650532 |
| 146 | Endometrial cancer_Homo sapiens_hsa05213 | 0.39079659 |

